WebMar 22, 2024 · Michael Hofman and colleagues 1 should be congratulated for their study reported in The Lancet, in which men (median age 68·1 years [IQR 63·0–73·5]) with high-risk prostate cancer were randomly assigned to standard imaging (CT and bone scan) or gallium-68 prostate-specific membrane antigen (PSMA) PET-CT. The study had a …
Jean Heather Hoffman-Censits, M.D., Assistant Professor of
WebAdditionally, he serves as a medical director for quality within the cancer center. In this role, he has led multiple improvement projects and helps to manage the Cancer Center … WebAug 7, 2024 · Progressive metastatic castration-resistant prostate cancer is a highly lethal disorder. In the randomised trial reported by Michael Hofman and colleagues,1 lutetium-177 [177Lu]Lu-PSMA-617, a small molecule delivering targeted radiation by binding to prostate-specific membrane antigen (PSMA), led to a higher proportion of patients having a 50% … potted bulbs after flowering
[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with ... - PubMed
WebPhilip C. Hoffman, MD, is an expert in cancers of the lung, breast and esophagus. He sees patients with all stages of these cancers. The author of more than 80 medical journal … WebSandra L. Hofmann, M.D., Ph.D., is a Professor in the Department of Internal Medicine at UT Southwestern Medical Center. She specializes in hematology and oncology. Dr. … WebMar 11, 2024 · New York, NY 10469 Hoffman Oncology, Excella-Bio, and Bruckner Oncology are all partners in the oncology clinical research and private practice … potted bulbs plant care